Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study

Item

http://www.wikidata.org/entity/Q35602143

Q35602143

about

Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Role, Controversy, and Future Directions.Chemotherapy protocols and incidence of oral mucositis. An integrative review.

P2860

Q52596125-8164B1CC-D10D-4D2E-9CB5-51269F21B40F Q55024194-3005EB5E-FF39-4011-83DF-AF043AE7E2FF

P2860

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study

Item

http://www.wikidata.org/entity/Q35602143

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Induction therapy with cetuxim ...... GERCOR phase II ECHO-07 study

@ast

Induction therapy with cetuxim ...... GERCOR phase II ECHO-07 study

@en

type

Item

label

Induction therapy with cetuxim ...... GERCOR phase II ECHO-07 study

@ast

Induction therapy with cetuxim ...... GERCOR phase II ECHO-07 study

@en

prefLabel

Induction therapy with cetuxim ...... GERCOR phase II ECHO-07 study

@ast

Induction therapy with cetuxim ...... GERCOR phase II ECHO-07 study

@en

P1476

Induction therapy with cetuxim ...... GERCOR phase II ECHO-07 study

@en

P2093

Aimery de Gramont

http://www.w3.org/2001/XMLSchema#string

Alain Banal

http://www.w3.org/2001/XMLSchema#string

Benoist Chibaudel

http://www.w3.org/2001/XMLSchema#string

Franck Bonnetain

http://www.w3.org/2001/XMLSchema#string

Frédéric Chabolle

http://www.w3.org/2001/XMLSchema#string

Jean Lacau St Guily

http://www.w3.org/2001/XMLSchema#string

Jean-Baptiste Belloc

http://www.w3.org/2001/XMLSchema#string

Magdalena Benetkiewicz

http://www.w3.org/2001/XMLSchema#string

Marine Lefevre

http://www.w3.org/2001/XMLSchema#string

Martin Housset

http://www.w3.org/2001/XMLSchema#string

P2860

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Human papillomavirus and survival of patients with oropharyngeal cancer.

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence.

HPV-associated head and neck cancer: a virus-related cancer epidemic.

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)

P304

721-731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.408

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Soussan

Sophie Perie

P577

2015-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272298100

http://www.w3.org/2001/XMLSchema#string

P698

25684313

http://www.w3.org/2001/XMLSchema#string

P921

cetuximab

P932

4430265

http://www.w3.org/2001/XMLSchema#string

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study

about

P2860

P2860

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932